Burkina Faso vs Iceland: Estimated antiretroviral therapy coverage among people living with HIV
Burkina Faso
87.0%
in 2025
Iceland
88.0%
in 2025
Burkina Faso rank
33rd
Iceland rank
31st
Estimated antiretroviral therapy coverage among people living with HIV over time
- Burkina Faso
- Iceland
How they compare
Iceland currently reports 88.0% against 87.0% in Burkina Faso, a difference of 1.0%.
Across all 26 years both countries report, Iceland has been ahead every year.
Burkina Faso ranks 33rd and Iceland ranks 31st of 143 countries.
Iceland has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Burkina Faso | Iceland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 7.8% | 44.7% | 36.9% | Iceland |
| 2010s | 47.6% | 61.1% | 13.5% | Iceland |
| 2020s | 76.3% | 80.7% | 4.3% | Iceland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher estimated antiretroviral therapy coverage among people living with hiv, Burkina Faso or Iceland?
- Iceland, at 88.0% against 87.0% in Burkina Faso as of 2025.
- What is the difference in estimated antiretroviral therapy coverage among people living with hiv between Burkina Faso and Iceland?
- 1.0%, with Iceland ahead.
- How many years of comparable data are there for Burkina Faso and Iceland?
- 26 years are reported by both, from 2000 to 2025.
- How do Burkina Faso and Iceland rank globally for estimated antiretroviral therapy coverage among people living with hiv?
- Burkina Faso ranks 33rd and Iceland ranks 31st of 143 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.